Drug resistance in malaria, tuberculosis, and HIV in South East Asia: biology, programme, and policy considerations
- PMID: 28874362
- PMCID: PMC5582343
- DOI: 10.1136/bmj.j3545
Drug resistance in malaria, tuberculosis, and HIV in South East Asia: biology, programme, and policy considerations
Abstract
Malaria, tuberculosis, and HIV present unique challenges in the control of antimicrobial resistance, and require targeted policies, say Samiran Panda and colleagues
Conflict of interest statement
Competing interest: We have read and understood BMJ policy on declaration of interests and have no relevant interests to declare.
Figures
References
-
- World Health Organization. Global health observatory data repository. Population data by WHO region. 2015. http://apps.who.int/gho/data/view.main.POP2020.
-
- Sharma A, Hill A, Kurbatova E, et al. Global Preserving Effective TB Treatment Study Investigators. Estimating the future burden of multidrug-resistant and extensively drug-resistant tuberculosis in India, the Philippines, Russia, and South Africa: a mathematical modelling study. Lancet Infect Dis 2017;17:707-15. 10.1016/S1473-3099(17)30247-5 pmid:28499828. - DOI - PMC - PubMed
-
- Koenderink JB, Kavishe RA, Rijpma SR, Russel FG. The ABCs of multidrug resistance in malaria. Trends Parasitol 2010;26:440-6. 10.1016/j.pt.2010.05.002 pmid:20541973. - DOI - PubMed
-
- Almeida Da Silva PE, Palomino JC. Molecular basis and mechanisms of drug resistance in Mycobacterium tuberculosis: classical and new drugs. J Antimicrob Chemother 2011;66:1417-30. 10.1093/jac/dkr173 pmid:21558086. - DOI - PubMed
-
- Jarlier V, Nikaido H. Mycobacterial cell wall: structure and role in natural resistance to antibiotics. FEMS Microbiol Lett 1994;123:11-8. 10.1111/j.1574-6968.1994.tb07194.x pmid:7988876. - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical